Shimadzu supports drug discovery
Shimadzu has announced that, in partnership with the Sugiyama Laboratory within the RIKEN Innovation Centre of the RIKEN Research Cluster for Innovation, it has started research on quantitative analysis methods using LC–MS–MS to support drug discovery using microdosing.
Shimadzu has announced that, in partnership with the Sugiyama Laboratory within the RIKEN Innovation Centre of the RIKEN Research Cluster for Innovation, it has started research on quantitative analysis methods using LC–MS–MS to support drug discovery using microdosing.
The RIKEN Innovation Centre invited Professor Yuichi Sugiyama, PhD, of the Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences at the University of Tokyo, Tokyo, Japan, to establish the Sugiyama Laboratory for the purpose of researching a system that provides comprehensive support for drug discovery by enabling in vitro and in vivo prediction of pharmacokinetics, efficacy and toxicity, prediction of interactions between drugs, variations between individuals or different pathologies.
Shimadzu has joined a total of 25 companies investing capital in establishing the Sugiyama Laboratory. In addition, Shimadzu has started developing an application system using its LC–MS system and high-sensitivity separation technology for clinical trials of microdosing and studies of cassette dosing.
For more information please visit ref="http://www.shimadzu.com/an/">www.shimadzu.com
Measuring Vitamin K1 Concentrations in Dogs with Chronic Enteropathy Using LC–MS/MS
May 14th 2025A joint study between the University of Tennessee (Knoxville, Tennessee) and the University of Pennsylvania School of Veterinary Medicine (Philadelphia, Pennsylvania) compared directly measured vitamin K1 (vitK1) concentrations in healthy dogs and dogs with chronic enteropathy (CE) using liquid chromatography tandem mass spectrometry (LC–MS/MS); they also investigated whether supplementation of vitK1 in dogs with CE would significantly increase vitK1 concentrations.
HPLC 2025 Preview: Fundamentally Speaking (Part 2)
May 14th 2025Michael Lämmerhofer from the Institute of Pharmaceutical Sciences, University of Tübingen, Germany, spoke to JFK Huber Lecture Award winner of 2024 Torgny Fornstedt, professor in analytical chemistry and leader of the Fundamental Separation Science Group, Karlstad University, Sweden, about his pioneering work in high performance liquid chromatography (HPLC) with a focus on fundamentals, ion-pair chromatography, and oligonucleotide applications.
